Global Life Science Instrumentation Market to Reach $79.8 Billion at a CAGR of 4.8% by 2027 – ResearchAndMarkets.com


DUBLIN–()–The “Life Science Instruments: Global Strategic Business Report” has been added to ResearchAndMarkets.com offering.

The global market for life science instruments will reach $79.8 billion by 2027

The global life science instruments market is expected to reach USD 79.8 billion by 2027, growing at a CAGR of 4.6%, driven by post-COVID-19 business transformation, valued at USD 58.2 billion in 2020. the period of analysis is 2020-2027. Spectroscopy, one of the segments analyzed in the report, is expected to register a CAGR of 4.8% and reach USD 19.2 billion by the end of the analysis period. Growth in the chromatography segment is revised to 5.2% CAGR over the next 7 years, given the ongoing post-pandemic recovery.

While the US market is valued at $16.9 billion, China is expected to grow at a CAGR of 4.2%.

The US market for life science instruments will reach $16.9 billion in 2020. is valued in dollars. China, the world’s second largest economy, is expected to reach USD 14.1 billion by 2027, surpassing the CAGR of 4.2%. The period of analysis is 2020-2027. Among other geographic markets, Japan and Canada are forecast to grow by 4% and 3.9%, respectively, from 2020 to 2027. In Europe, Germany’s CAGR is expected to grow at around 3.4%.

PCR segment to register 5.8% CAGR

In the global PCR segment, the United States, Canada, Japan, China, and Europe will drive the estimated CAGR of 5.8% for this segment. In 2020, these regional markets will account for a total of USD 6.6 billion and will reach USD 9.9 billion by the end of the analysis period. China will continue to be one of the fastest growing countries in this cluster of regional markets.

Pick Opponents (Total 44 Featured) –

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • BioTek Instruments, Inc.

  • Bruker Corporation

  • ChromaCode

  • Danaher Corporation

  • Eppendorf AG

  • GE Healthcare

  • Hitachi High-Tech Corporation

What’s new in 2022?

  • Global competitiveness and market share of major competitors

  • Presence in multiple geographic markets – Strong/Active/Niche/Minor

  • Online interactive peer-to-peer custom updates

  • Access to digital archives and research platforms

  • Free updates for one year

Key topics covered:

I. METHODOLOGY

II. SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • Global market trajectory

  • The impact of Covid-19 and the global economic crisis

  • Life Science Instruments – Global Market Share of Key Competitors 2020 (E)

  • Competitive Market – Strong/Active/Niche/Imperative for Global Players in 2020 (E)

2. ATTENTION TO SELECTED PLAYERS

3. MARKET TRENDS & DRIVERS

4. WORLD MARKET PROGRAM

III. MARKET ANALYSIS

IV. COMPETITION

Featured companies

  • Agilent Technologies, Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories, Inc.

  • BioTek Instruments, Inc.

  • Bruker Corporation

  • ChromaCode

  • Danaher Corporation

  • Eppendorf AG

  • GE Healthcare

  • Hitachi High-Tech Corporation

For more information on this report, visit https://www.researchandmarkets.com/r/vjo716



Source link

Leave a Comment